Cell
Banking
Regulatory agencies worldwide require a continuing
and well-controlled supply of the specific cell lineage
that is integral to the manufacturing process of a
biopharmaceutical.
Let WuXi Advanced Therapies’team of experienced cell
culture specialists – with the oversight of our highly
trained quality assurance unit – manufacture your banks
to the highest standards to meet global expectations.
Batch Record Development
• Consultation to determine needs
• Clarify raw materials and process
requirements
• Creation of a batch record to document a
comprehensive cell line history, growth
profile and safety & characterization data
ex p e r t i se
Cell Expansion & Harvest
• Capacity to manufacture 10-1,200 vials
• Campaign production approach
• Stringent raw materials release program
• Thorough seed stock contamination
acceptance screening
• Validated change-over and cleaning
procedures
Testing & Characterization
• Recovery viability
• Growth
• Complete biosafety
• Genetic characterization
Documentation
• 100% QA raw data review
• QA-approved Certificate
of Analysis
Human
324K
A549
BJAB
CEM-A
HEK 293
H9
HeLa
Hs-68
HT-1080
MRC-5
MSC
Neuroblastoma
PER-C6
RD
Spleen
TALL264
Umbilical cord
WI-38
Bovine
BT
MDBKs
Monkey
B-95
CV-1
LLC MK2
MA104
VERO
Murine
BALB 3T3
Hybridoma
L929
NSO
Mus dunni
NIH 3T3
SC-1
Sp2/0
Porcine
PK-15
PT-1
ST
Rat
XC
CELL BANKING EXPERIENCE
CELL CULTURE
PLATFORMS
T-Flasks • Shaker Flasks
Spinner Flasks • Roller Bottles
Cell Factories • Hyperstacks
Canine
MDCK
Chicken
Embryo
Equine
NBL-6
Feline
PG4
Hamster
BHK-21
CHO
Insect
Drosophila
High-5
S2
Sf9
Mink
*Includes cell, cell line banking for both GMP and testing purposes
Regulatory agencies worldwide require a continuing
and well-controlled supply of the specific cell lineage
that is integral to the manufacturing process of a
biopharmaceutical.
Let WuXi Advanced Therapies’team of experienced cell
culture specialists – with the oversight of our highly
trained quality assurance unit – manufacture your banks
to the highest standards to meet global expectations.
Batch Record Development
• Consultation to determine needs
• Clarify raw materials and process
requirements
• Creation of a batch record to document a
comprehensive cell line history, growth
profile and safety & characterization data
ex p e r t i se
Cell Expansion & Harvest
• Capacity to manufacture 10-1,200 vials
• Campaign production approach
• Stringent raw materials release program
• Thorough seed stock contamination
acceptance screening
• Validated change-over and cleaning
procedures
Testing & Characterization
• Recovery viability
• Growth
• Complete biosafety
• Genetic characterization
Documentation
• 100% QA raw data review
• QA-approved Certificate
of Analysis
Human
324K
A549
BJAB
CEM-A
HEK 293
H9
HeLa
Hs-68
HT-1080
MRC-5
MSC
Neuroblastoma
PER-C6
RD
Spleen
TALL264
Umbilical cord
WI-38
Bovine
BT
MDBKs
Monkey
B-95
CV-1
LLC MK2
MA104
VERO
Murine
BALB 3T3
Hybridoma
L929
NSO
Mus dunni
NIH 3T3
SC-1
Sp2/0
Porcine
PK-15
PT-1
ST
Rat
XC
CELL BANKING EXPERIENCE
CELL CULTURE
PLATFORMS
T-Flasks • Shaker Flasks
Spinner Flasks • Roller Bottles
Cell Factories • Hyperstacks
Canine
MDCK
Chicken
Embryo
Equine
NBL-6
Feline
PG4
Hamster
BHK-21
CHO
Insect
Drosophila
High-5
S2
Sf9
Mink
*Includes cell, cell line banking for both GMP and testing purposes
The Advanced Therapies business unit of WuXi AppTec is a
global Contract Development and Manufacturing Organization
dedicated to accelerating and transforming development, manufacturing,
and commercialization of cell, gene, and other advanced therapies.
Accelerating Progress
and Time to Market
Integrated CDMO and Testing Service Platform
advancedtherapies.com
CONNECT WITH US
WuXiATU-112-110118

Cell Banking

  • 1.
  • 2.
    Regulatory agencies worldwiderequire a continuing and well-controlled supply of the specific cell lineage that is integral to the manufacturing process of a biopharmaceutical. Let WuXi Advanced Therapies’team of experienced cell culture specialists – with the oversight of our highly trained quality assurance unit – manufacture your banks to the highest standards to meet global expectations. Batch Record Development • Consultation to determine needs • Clarify raw materials and process requirements • Creation of a batch record to document a comprehensive cell line history, growth profile and safety & characterization data ex p e r t i se Cell Expansion & Harvest • Capacity to manufacture 10-1,200 vials • Campaign production approach • Stringent raw materials release program • Thorough seed stock contamination acceptance screening • Validated change-over and cleaning procedures Testing & Characterization • Recovery viability • Growth • Complete biosafety • Genetic characterization Documentation • 100% QA raw data review • QA-approved Certificate of Analysis Human 324K A549 BJAB CEM-A HEK 293 H9 HeLa Hs-68 HT-1080 MRC-5 MSC Neuroblastoma PER-C6 RD Spleen TALL264 Umbilical cord WI-38 Bovine BT MDBKs Monkey B-95 CV-1 LLC MK2 MA104 VERO Murine BALB 3T3 Hybridoma L929 NSO Mus dunni NIH 3T3 SC-1 Sp2/0 Porcine PK-15 PT-1 ST Rat XC CELL BANKING EXPERIENCE CELL CULTURE PLATFORMS T-Flasks • Shaker Flasks Spinner Flasks • Roller Bottles Cell Factories • Hyperstacks Canine MDCK Chicken Embryo Equine NBL-6 Feline PG4 Hamster BHK-21 CHO Insect Drosophila High-5 S2 Sf9 Mink *Includes cell, cell line banking for both GMP and testing purposes
  • 3.
    Regulatory agencies worldwiderequire a continuing and well-controlled supply of the specific cell lineage that is integral to the manufacturing process of a biopharmaceutical. Let WuXi Advanced Therapies’team of experienced cell culture specialists – with the oversight of our highly trained quality assurance unit – manufacture your banks to the highest standards to meet global expectations. Batch Record Development • Consultation to determine needs • Clarify raw materials and process requirements • Creation of a batch record to document a comprehensive cell line history, growth profile and safety & characterization data ex p e r t i se Cell Expansion & Harvest • Capacity to manufacture 10-1,200 vials • Campaign production approach • Stringent raw materials release program • Thorough seed stock contamination acceptance screening • Validated change-over and cleaning procedures Testing & Characterization • Recovery viability • Growth • Complete biosafety • Genetic characterization Documentation • 100% QA raw data review • QA-approved Certificate of Analysis Human 324K A549 BJAB CEM-A HEK 293 H9 HeLa Hs-68 HT-1080 MRC-5 MSC Neuroblastoma PER-C6 RD Spleen TALL264 Umbilical cord WI-38 Bovine BT MDBKs Monkey B-95 CV-1 LLC MK2 MA104 VERO Murine BALB 3T3 Hybridoma L929 NSO Mus dunni NIH 3T3 SC-1 Sp2/0 Porcine PK-15 PT-1 ST Rat XC CELL BANKING EXPERIENCE CELL CULTURE PLATFORMS T-Flasks • Shaker Flasks Spinner Flasks • Roller Bottles Cell Factories • Hyperstacks Canine MDCK Chicken Embryo Equine NBL-6 Feline PG4 Hamster BHK-21 CHO Insect Drosophila High-5 S2 Sf9 Mink *Includes cell, cell line banking for both GMP and testing purposes
  • 4.
    The Advanced Therapiesbusiness unit of WuXi AppTec is a global Contract Development and Manufacturing Organization dedicated to accelerating and transforming development, manufacturing, and commercialization of cell, gene, and other advanced therapies. Accelerating Progress and Time to Market Integrated CDMO and Testing Service Platform advancedtherapies.com CONNECT WITH US WuXiATU-112-110118